Navigation Links
Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo'
Date:4/17/2008

SALT LAKE CITY, April 17 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced the introduction of two new products: the DynaPro Spinal Health System for treating back pain and the Dynatron X5 "Turbo" soft-tissue oscillation therapy unit.

"The new DynaPro Spinal Health System uses a four-phase treatment regimen combining the benefits of decompression with light therapy, core-stabilization exercises and nutrition," said Larry K. Beardall, executive vice president of sales and marketing. "Decompression therapy has been shown effective in relieving pain associated with a host of back problems including herniated discs, degenerative disc disease, sciatica and pinched nerves."

In addition to offering the most comprehensive approach to the effective treatment of many of the most common causes of back and neck pain, the DynaPro Spinal Health System incorporates a state-of-the-art marketing and patient- awareness program to help practitioners promote this proven, non-surgical pain relief treatment. With Dynatronics' revolutionary "Play Before You Pay" program, practitioners are able to "test drive" the concept by pre-marketing treatments prior to purchasing the system.

Another new product introduced this month is also being well received by the rehabilitation market. The new Dynatron X5 "Turbo" is three times more powerful than the original X5 device. It creates an electrostatic field within the patient that results in a highly effective treatment for acute as well as chronic pain. Soft-tissue oscillation therapy has proven to be very effective in the treatment of various orthopedic and sports injuries, and is gaining popularity in sports medicine.

"We notice immediate reductions in acute edema and joint stiffness," reported Mike Cembellin, Director of Sports Medicine, Santa Clara University. "The results from the X5 are impressive."

"We believe there is remarkable potential for both these new products," added Beardall. "The demand they will generate is expected to raise our fourth quarter results higher than previously anticipated."

Initial shipments of the new DynaPro Spinal Health System and the X5 "Turbo" have begun this month.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets.

This press release contains forward-looking statements. Those statements include references to the company's expectations of future events. Actual results may vary from the views expressed in the forward-looking statements, including but not limited to references to efficacy of treatments, potential for the new products, expectations concerning operating results ahead of previous expectations. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, FDA clearance of new products, and the risk factors listed from time to time in the company's SEC reports, including, but not limited to the report on Form 10-KSB for the year ended June 30, 2007 and subsequent quarterly reports.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics Introduces New Synergie Elite Aesthetic Line
2. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
3. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
4. Dynatronics Announces $250,000 Increase in Stock Buyback Program
5. Dynatronics Acquisitions Increase Sales 91 Percent in First Quarter
6. Dynatronics to Release First Quarter Results Monday, November 19, 2007; Conference Call Set for 1:30 p.m. ET
7. Dynatronics Adds Three Additional Direct Sales Reps
8. Dynatronics Announces Strong Fourth Quarter Profit
9. GHX Introduces NuVia(TM), an Artificial Intelligence-based Technology That Enables a New Approach to Content Management for Healthcare Providers
10. Mediware Introduces Comprehensive Vision for Blood Center Technology
11. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand marijuana ... the Icahn School of Medicine at Mount Sinai has found. The study was ... children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, ... Device Remote Control through a new partnership with Splashtop Inc. This remote control ... mobile solutions to help businesses maximize their uptime and productivity. , Wavelink offers ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
(Date:12/7/2016)... Yorba Linda, Ca (PRWEB) , ... December 07, 2016 , ... ... to attain that funding is with useful, properly analyzed data. The team at Beckman ... generation to address the 'need for speed' and the need to operate in a ...
(Date:12/7/2016)... ... 2016 , ... A quote from Dr. Edward Hallowell, host of CRN International’s ... offer a rare glimpse into the mind of those people with ADHD. , Dr. ... author, has described people with ADHD as having “Ferrari engines for a brain, with ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... REPORT OBJECTIVES The report ... intelligence on a market segment, based on geography. ... in the report. The primary objectives of this ... intelligence through detailed segmentation, 2) market size and ... developments, market situation, trends, 3) detailed analysis of ...
Breaking Medicine Technology: